MedPath

Improved Bowel Preparation Method for Colonoscopy Based on Different Risk Stratification

Not Applicable
Completed
Conditions
Bowel Preparation Before Colonoscopy
Interventions
Drug: PEG+lactulose
Drug: PEG
Registration Number
NCT04582942
Lead Sponsor
Renmin Hospital of Wuhan University
Brief Summary

The purpose of this study is to evaluate the efficacy of polyethylene glycol(PEG) combined with lactulose for bowel preparation before colonoscopy in low-risk patients and high-risk patients.

Detailed Description

The quality of bowel preparation is crucial for colonoscopy. Some high-risk factors for inadequate bowel preparation have been identified , including age \>70, previous colon surgery, constipation, diabetes, Parkinson's disease, history of stroke or spinal cord injury, prior history of inadequate bowel preparation, body mass index (BMI) \>25, use of tricyclic antidepressant or narcotics. Patients were considered as high risk if they have any of the above factors and considered as low risk if they did not have any of these risk factors.This is a multicenter, endoscopist-blinded study to compare the efficacy of PEG combined with lactulose and PEG alone in bowel preparation. In colonoscopy procedures, endoscopists who were blinded to the intervention evaluated the overall quality of colonoscopy cleaning according to the Boston Bowel Preparation Scale. Patients' tolerance, defecation, adverse events and adenoma detection rate (ADR) were also evaluated.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2028
Inclusion Criteria
  • Adults undergoing colonoscopy.
Read More
Exclusion Criteria
  • 1.presence of any contraindications for colonoscopy (gastrointestinal obstruction or perforation,severe acute inflammatory bowel disease,toxic megacolon,severe heart failure,unable to swallow,severe heart failure,etc);
  • 2.Patients with galactosemia;
    1. hypersensitivity to any of the ingredients;
  • 4.Pregnancy or lactation;
  • 5.Use of lactulose,prokinetic agents or purgatives within 7 days;
  • 6.Unwilling to sign informed consent.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PEG+lactulose (low-risk patients and high-risk patients)PEG+lactuloseThe dosing regimen of low-risk patients and high-risk patients will be PEG combined with lactulose.
PEG (low-risk patients and high-risk patients)PEGThe dosing regimen of low-risk patients and high-risk patients will only be PEG.
Primary Outcome Measures
NameTimeMethod
Boston Bowel Preparation Scaleduring colonoscopy

Cleanliness of the colon during colonoscopy will be evaluated by the Boston Bowel Preparation Scale which is a 4-point scoring system applied to each of 3 broad regions of the colon: the right side, the transverse section, and the left side. The total BBPS score ranged from 0 to 9. If total BostonBowel Preparation Score ≥6 with each segmental BBPS≥2, we regard it as adequate bowel preparation.

Secondary Outcome Measures
NameTimeMethod
defecation frequency2 days

Frequency of bowel movement.

Rate of adverse events2 days

adverse events, such as vomiting, nausea, headache, abdominal distention,abdominal pain.

Withdrawal timeduring colonoscopy

The time from the cecum to the anus, but excluded time for biopsy performance or removal of polyps.

Adenoma Detection Rate2 days

Diagnosis was confirmed by histologic examination

Cecal intubation rateduring colonoscopy

Colonoscopy reaches cecal region.

Cecal intubation timeduring colonoscopy

Colonoscopy reaches cecal region.

Willingness to repeat bowel preparation2 days

The number of patients have a willingness to undergo a repeated bowel preparation if needed.

Trial Locations

Locations (1)

Renmin Hospital of Wuhan University

🇨🇳

Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath